Invention Grant
- Patent Title: Antigen specific multi epitope-based anti-infective vaccines
-
Application No.: US13384286Application Date: 2010-07-15
-
Publication No.: US09642903B2Publication Date: 2017-05-09
- Inventor: Lior Carmon
- Applicant: Lior Carmon
- Applicant Address: IL Tel-Aviv IL Nes-Ziona
- Assignee: LIOR CARMON,VAXIL BIOTHERAPEUTICS LTD.
- Current Assignee: LIOR CARMON,VAXIL BIOTHERAPEUTICS LTD.
- Current Assignee Address: IL Tel-Aviv IL Nes-Ziona
- Agency: Roberts Mlotkowski Safran Cole & Calderon, P.C.
- International Application: PCT/IL2010/000569 WO 20100715
- International Announcement: WO2011/007359 WO 20110120
- Main IPC: A61K39/12
- IPC: A61K39/12 ; A61K39/00 ; A61K31/04 ; A61K39/09 ; A61P37/04 ; A61K39/04

Abstract:
Provided are peptide vaccines including the signal peptide domain of selected target antigens of intracellular pathogens. The peptide vaccines of the invention contain multiple class II and class I-restricted epitopes and are recognized and presented by the majority of the vaccinated human population. Further provided, in particular, are anti tuberculosis vaccines. Also further provided are compositions including the vaccines as well as their use to treat or prevent infection.
Public/Granted literature
- US20120177677A1 ANTIGEN SPECIFIC MULTI EPITOPE-BASED ANTI-INFECTIVE VACCINES Public/Granted day:2012-07-12
Information query